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ABSTRACT

32-microgl°bulin (32a) has been purified over 1500fold from the serum of miniature swine poisoned with sodium
chromate.

Relative to the amount of

original serum sample,

a 52.2% yield was obtained.

logous radioimmunoassay (RIA)
$2y

inhibition test

and goat-anti-rabbit (GAR)

fractions containing swine
purification procedure.

activity in the

32a

A hetero-

(using

125

I-human

$2a) was used to detect
activity in each step of the

A procedure of gel chromatography with

Sephadex G-75 followed by ion exchange chromatography with DEAEcellulose was used in the purification.

Additional attempts

to purify the £2a by isoelectric focusing and ion exchange
chromatography with CM-cellulose were not successful.

Preliminary

SDS polyacrylamide gels revealed an 11,000 Dalton putative
peak free of most contaminants.
a goat,

This

62a

62a

has been used to immunize

and initial Ouchterlony immunodiffusion tests have shown

the ability of the goat-anti-swine
with the purified swine

62a-

62a

to form precipitin lines

INTRODUCTIC

g 2-microglobulin (g2y)
many cell types,

is a small protein produced by

including lymphocytes and cells of epithelial

and mesenchymal origin (10,40,47).
cell,

After synthesis within the

it can either be transported to the cell surface,

or it

can be secreted and is thus found to a snail extent in normal
body fluids (41).

The protein was named on the basis of its

snail size and its

B globulin electrophoretic mobility (49).

First isolated from human urine (8),

homologues of 32a have now

been isolated and purified from many species,
pig (16),

rabbit (6,20,21), mouse (2,39,53),

rat (48),

and chicken (66).

dog (57),

These homologues of B21-J

structural characteristics.
about 100 amino acids,

including guinea

B2V1

share many

They are all simple polypeptides of

containing no carbohydrate,

and have

molecular weights between 11,000 and 13,000 Daltons.
the cow

cow (31),

homologue are monomeric,

All except

with one intrachain disulfide

bond forming a loop involving 57 amino acids.
The kidney is responsible for much of the catabolism of ggiu
Like many small proteins, 32U is filtered through the glomerulus
and is reabsorbed and catabolyzed by proximal tubular cells (8,26).
Under normal circumstances,

only small amounts of 3 2u can be

measured in serum and urine, but in cases of renal failure and
tubular damage,

the serum and urinary levels of 3 2'J may increase

more than a thousandfold (44).

Increased serum levels are also

seen in lymphoproliferative disorders (9).
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These cases provide a

source from which Bov*

may be isolated.

The study of B^p has become an area of great interest to
imnunologists because of the resemblance of BoP ho subunits of
immunoglobulins and because it has been found to be a subunit of
histocompatibility antigens.

The structural similarities among

these molecules may imply that they share a similar function,
well as a common evolutionary origin.

as

Therefore it is important

to study B2P as a model which may clarify the functions of and
interrelationships among certain other important cell surface
proteins.
Relationship with Immunoglobulins.
observations about

One of the first

B2P was that its structure resembled that of

the constant regions of an inmunoglobulin G (IgG) domain (19,20,22).
Both contain about the same number of amino acids and have one
intrachain disulfide bond.

Each has a compact globular structure

with seme B-pleated sheet regions.

Most importantly,

considerable amino acid homology between the two,

there is

particularly

between B2P and the C^3 region of IgG (28% homology).

This

homology is comparable to the homology among the IgG constant
region domains.

B2P also shows homology to about the same extent

with the constant regions of IgM and IgE (19).
In addition to these structural similarities,
IgG in some of its functions.

B2P resembles

It can interact with the first

component of the complement system like the Fc portion (%3 region)
of IgG,

and when aggregated,

-

2

can activate complement (43).

-

It is

similar to C^3 in its ability,
cells,
C^3,

when attached to sheep red blood

to form rosettes with guinea pig macrophages (43).
2^

$

Like

can also bind to the Fc receptor of lymphocytes (46).

There are some significant differences,
B2P and inmmoglobulin constant regions.
are made only by plasma cells, 62^

however,

between

While immunoglobulins

is made by many nonlymphoid cell

types as well as lymphocytes (40).

The synthesis of

&2y

Is n°l

linked to inmmoglobulin synthesis.

Another important difference

is that antisera to immunoglobulins

will not react with B21-1

(8,15).

Inspired by the associations between B2M and immunoglobulins,
two major hypotheses have been proposed for the evolutionary origin
of B2U•

One is that B2V

is a modern descendant of an immunoglobulin

precursor gene, which later duplicates to code for the homologous
constant regions of the immunoglobulin molecule (21,22,27,43,46).
According to this theory,

B2^

is equivalent to a free Cq3 domain.

Evidence supporting this hypothesis includes the presence in
invertebrates that lack immunoglobulins,
indicating that

of homologues of

2^

^

2^jhylogenetically precedes immunoglobulins.

$

>

This

is also indicated by the presence of B2W on nonlymphoid cells.
Homology with the constant regions of all classes of immunoglobulins
is also evidence that 62^ occurred first,
from its duplication.
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and immunoglobulins arose

The second major hypothesis about the origin of
that the gene for

62 u

claims

arose after the duplication of the immuno¬

globulin precursor molecule,

from a deletion of a segment in the

IgG H chain precursor gene (58).

The gene for 62^ would then include

a short segment of the C^2 region and most of the C^3 region.

This

hypothesis is supported by the fact that both structurally and
functionally,

B2P most resembles the <3^3 region,

yet it fails to

explain why 69M would be as similar to IgM and IgE as it is to IgG.
B2a is not likely to be the result of a proteolytic cleavage
of a larger immunoglobulin for several reasons.
fraying at what would be the cleaved end.

There is no

Also the amino acid

sequence does not correspond exactly to a region of any known
immunoglobulin.

Antisera to the known classes of immunoglobulins

do not react with 32^*
Relationship with Major Histocompatibility Antigens.

The

serologically determined major histocompatibility antigens (in
mice,

the K and D region antigens) may be composed of four poly¬

peptide chains,

two heavy chains linked by a disulfide bond and

two light chains noncovalently bonded to the heavy chains (very
similar to immunoglobulin structure).

The noncovalent bonding

is inferred from the ability to separate the heavy and light chains
from each other by low pH without reduction and alkylation (45).
This four chain model is not universally accepted,
may be due to a solubilization artifact.

however,

and

The alternate structure

that has been proposed is a single heavy and light chain non¬
covalently bonded (01).

An association between 621-1 and human histo¬

compatibility (HLA) antigens was first postulated when an 11,000
MW fragment was isolated from human lymphoid cell culture medium
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and found to have an identical amino acid composition to human
Boy

(37).

Evidence for a structural association between HLA

antigens and B2y has been shown by co-capping experiments (50,59,
60).

Capping is a manifestation of the mobility of membrane

proteins.

Antibodies to cell surface determinants cause redis¬

tribution of these determinants into patches on the cell membrane,
followed by energy-dependent migration of these patches to form a
cap at either pole of the cell.
lized for seme proteins,

This aggregate may then be interna¬

and the membrane protein is regenerated

in three to eight hours (56).

Treatment of lymphocytes with anti¬

serum against B2I leads to co-capping of HLA determinants and 32^,
whereas treatment of the cells with antiserum against HLA antigens
induces capping of HLA antigens and only some cell surface B2y*
This occurs on other cell types in addition to lymphocytes (59).
This experiment indicates that
determined HLA antigens,

B2I-1 is associated with all serologically

but that the number of B2y molecules on the

cell surface is in excess of the number of HLA antigens (by a sixto-one ratio,
cell-surface

as later determined (41)).

Therefore,

is associated with HLA antigens,

cell surface antigens or receptors (7,41),

some of the

some with other

and up to half of the 321

is unassociated with other antigens (33).
Another experiment which shows an association between B2u and
HLA antigens involves the ability of antisera against
HLA antigens as well as 321

(30).

5
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S2u to precipitate

After lysis of radiolabelled

lymphocytes with a nonionic detergent,

the cell lysates were sub¬

jected to iirmunoprecipitation with anti-^a*

The precipitates were

analyzed by sodium dodecyl sulfate - polyacrylamide gel electro¬
phoresis (SDS - PAGE),

giving two peaks of radioactivity,

ponding to 45,000 MW and 11,000 MW (33).

The 45,000 MW peak repre¬

sents the detergent-solubilized HLA antigen without
11,000

MW peak is £31,

corres¬

62a,

while the

showing that their association can be dis¬

rupted by denaturing conditions.
Through further experiments it was discovered that not only is
62a

associated with HLA antigens,

but 3ga

is the small subunit or

"comm portion fragment (cpf)" of HLA antigens (30,37,62).

This

was shown by both structural and functional identity of

and

HLA-cpf.

62a

A direct structural comparison was done to determine anti¬

genic and physiochemical properties and amino acid sequence.

Anti¬

genic identity was established using a double Ouchterlony technique
(62), with antisera to

62a

and HLA-cpf in two center wells,

encircled by wells containing

32a

each

and wells containing HLA-cpf.

Lines of identity were obtained throughout.

Physiochemical identity

was shown by the single band obtained with SDS - PAGE and disc
electrophoresis of

32^

and HLA-cpf molecules,

of molecular size and ionic charge,

indicating identity

respectively (62).

Both

molecules showed a major dense sharp band at an isoelectric point
of 5.0 with isoelectric focusing (IEF),
ionic charge.

reinforcing the identity of

The amino acid sequences were identical for the

first 24 amino acids studied (62).
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Another experiment showing that $2y

is the small subunit

of HLA antigens (45) used papain-solubilized
and

125

After reduction and alkylation,

Sepharose showed

131

MW and 12,000 MW,

I-HLA antigens
fractionation on

I activity at peaks corresponding to 33,000

and

125

I activity at 12,000 MW.

The 12,000

MW fraction containing t31j activity from the HLA molecule and
125

I activity from 321-1 was examined with two dimensional electro¬

phoresis and chromatography,

and near identity was found.

It was

then demonstrated that reconstitution of the HLA molecule was
possible with unlabelled 33,000 MW fragment and labelled 32^this was done,

When

some of the label was seen associated with the

33,000 MW protein,

indicating that

32^ was a part of the recon¬

stituted HLA antigen.
The 32^ subunit of all HLA antigens appears to be invariant,
while the larger subunit is the region carrying the antigenic
specificity (45).

A question not yet answered is whether 32^

modulates the antigenic expression of HLA antigens in a manner
similar to the effect of the light chain (L) on the heavy chain
(H) of imnunoglobulins (51).

32^ may alter the availability of some

HLA antigenic determinants (63),

or may be required for the surface

expression of HLA antigens (17).

This is supported by the absence

of HLA antigen expression on the surface of cells from the Daudi
cell line,

a human cell line that cannot make

3^

.

Relationship with Mouse Thymus Leukeria (TL) Antigens. Thymus
leukemia antigens are cell surface proteins found only on T lympho¬
cytes and lymphoma cells in mice and are coded for by a locus
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adjacent to the major histocompatibility complex (H-2).
very similar in structure to the mouse H-2 antigens.

They are

The snail

invariant subunit has been found to be BpM (1,65), shown by
migration identical to a Bg^ control on SDS - PAGE.

The snail sub¬

units are bound noncovalently to two disulfide-linked heavy chains
carrying the alloantigenic determinants.
Relationship with Mouse Ss Protein.

The Ss protein is a

molecule coded for by the S locus of the H-2 complex, to date the
only locus of the H-2 which controls a molecule not integrated into
the cell surface (47).

It has been found to be the murine equivalent

of human complement component C4 (23).

It also is composed of two

subunits, one 23,000 MV and the other 12,000-14,000 MW.

The

smaller, which is devoid of carbohydrate and contains a single
intrachain disulfide bond, may be 3^(14).

If this is so,

it implies

important interrelationships among histocompatibility antigens, the
complement system, and inrnunoglobulins.
Relationship with Imnune Response-Associated (la) Antigens.
Ia antigens are coded for by the I region of the mouse H-2 complex.
They are found only on limited cell types,

including lymphocytes

(mainly B cells), spermatozoa, macrophages, and epidermal cells (13).
The mixed lymphocyte reaction (MLR) detects differences in I region
products, so Ia antigens are described as being "lymphocytedetermined".

In the MLR it is mainly B cells which stimulate a

response and T cells which respond to allogeneic Ia antigens on the B

8-
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cell surface by proliferation.

It was found that when the

responder T cells were treated first with antisera to ^
proliferative MLR response was inhibited (35).

> their

The antibodies may

interfere with recognition of the allogeneic la antigen by the T
cell.

This could indicate that they may be bound to an la receptor

of T cells, which thus may contain
conclusively.

but this has not teen shown

If the stimulator B cells are treated first with

anti-B2U, T cells in the MLR still respond with normal proliferation
whereas B cell treatment with antisera to la antigens leads to
inhibition of the T cell proliferative response (47).

This seams

to indicate that ^ is not a subunit of the la antigen, since anti¬
sera to

did not appear to block the la antigen.

Cell surface

la antigens solubilized from murine lymphocytes do not seen to be
associated with 821-b

yet la antigens secreted by lymphocytes and

obtained without chemical extraction do show an association with 62^
(3,13).

Ia antigens can be identified in serum, associated with

high density lipoproteins (HDL) as well as possibly with B2U (12,13)
It is not yet known if this difference between secreted and cellbound Ia antigens is real or merely an artifact or a consequence
of isolation technique.
Relationship with Allogeneic Effect Factor (AEF).

AEF is a

soluble irunune mediator made by alloantigen-activated T cells
which regulates triggering and differentiation of B cells in vitro
(2,3)o

It is not antigen-specific.

histocompatibility antigens,

Like immunoglobulins and

it is made up of two kinds of subunits.
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The 40,000 MW subunit contains la antigenic determinants, while
the 12,000 MW fragment appears identical to Bov(3).

AEF can be

completely and specifically absorbed by anti-BgiJ (3).

AEF is the

first molecule with I region determinants discovered to contain
B2U as part of its structure.

This association may indicate that

32P plays a role in cell-cell interactions.
Relationship

with the T Cell Receptor.

While the B cell

receptor for antigen has been found to be cell surface immunoglobulin,
the nature of the T cell receptor has remained a mystery.
been postulated that

It has

> with its similarity to immunoglobulin

structure and its linkage with histocompatibility antigens, may be
a subunit of the T cell receptor (4,60).

To investigate this, the

effect of anti-^y on responder and effector functions of T cells
was observed.

Anti-B2W inhibited the proliferative response of T

cells to mitogens (e.g. PHA), to antigens to which the T cells were
sensitized (e.g. PPD), and to alloantigens in the MLR.

This inhibi¬

tion could be prevented by addition of pure B2^ which bound to the
anti-32y , preventing its action on T cells.
of T cells is also inhibited by anti-32y

The effector function

, as shown by the ability

of anti-Bgy to block cell-mediated lympholysis (CML).
prevented by the addition of purified 82^
will preferentially bind (4).

This can be

» to which the anti-32V

These findings favor the involvement

of 3£W in the T cell receptor.

However the invariance or lack of

polymorphism of 32^ argues against its role as a T cell receptor
subunit, because it would appear to be incapable of mediating
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differential receptor activity (4).
on T cell responder and effector

Also the effects of anti-BoiJ

functions may be explained without

invoking a necessary link between Bgy and the T cell receptor.

A

disturbance of the cell membrane by anti-32V-1 rnay cause the inhibition
of T cell response to stimuli.

So the question of whether Bgy is a

part of the T cell receptor remains unsettled.
Studies of B21-1

in many different species give information about

the degree of genetic polymorphism or conservation of structure of
32U that exists among species.
insight into the structural,

This is important in order to gain

functional,

and evolutionary relation¬

ships that exist among 32^ inmunoglobulins,

histocompatibility antigens,

and other cell surface molecules.
While most work done in the past in transplantation biology
has utilized the mouse and its well-defined

11-2

disadvantages to the use of such a small animal.

complex,

there are

Many animals are

required to obtain a quantity of antigen sufficient for biochemical
characterization.

Also the mouse is not an adequate model for the

transplantation of some organs and tissues.

It was for these reasons

that a large animal model suitable for transplantation studies was
sought.

Miniature swine were chosen for their size and favorable

breeding characteristics (54).
to six months of age,

They reach sexual maturity at four

have an estrous cycle of three weeks,

a gestation period of about four months.

and have

Homozygosity of the major

histocompatibility complex was established by inbreeding miniature swine
(55).

11-
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Analysis of the swine major histocompatibility antigens by
SDS electrophoresis has shown a 42,000 MW peak (miniature swine
leukocyte antigens or MSLA,

comparable to the HLA and the mouse H-2)

and an 11,000 MW peak (the putative miniature swine62w)
isolation of this miniature swine B2u,

(36)-

The

which is the main topic of

this paper, was undertaken in order to study different inmunological
parameters in the pig.
model,

Since this animal is a good transplantation

it was desirable to learn more about the antigens making up

its major histocompatibility complex.

B2u has previously been isolated

and purified from several different species.
Human

was the first to ^ isolated.

It was obtained from

the urine of patients with impaired renal tubular function as a
result of Wilson's disease or chronic cadmium poisoning (8).
isolation procedure had four main steps:
dialysis tubing to concentrate the urine;

The

1) ultrafiltration using
2) preparative zone

electrophoresis in a Pevikon block,

first in barbital buffer and then

after concentration ctf the $2^ Peak>

in borate buffer (this separates

the urinary proteins according to their charge);

3) gel filtration

or gel chromatography with a Sephadex G-100 column to separate
molecules according to their molecular weight; 4)
chromatography,
Sephadex.

ion exchange

first with DEAE-cellulose and then with sulfoethyl

Column eluates were analyzed through all these steps by

the Folin method to determine total protein,

and by Ouchterlony

technique or radial imnunodiffusion (RID) to determine Br>y levels*
Confirmation of the purity of the isolated B2y
procedures:

obtained by four

1) Ouchterlony imnunodiffusion, which showed that B2p

present in plasma and urine gave a line of identity with purified
g2y

;

2) starch gel electrophoresis, which resulted in one zone

12-
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free of contaminants;
showed only one band;

3)

irmiunoelectrophoresis (IEP),

which

and 4) equilibrium ultracentrifugation,

which

showed a molecular weight of 11,600 for the purified 62^ molecule.
A simplified method of isolating 32U from urine involved the
use of affinity chromatography with anti-BgU
to bind $2y and HLA antigens,
proteins (42).

iirmunoadsorbent columns

separating them from other urinary

Another method also using urine as a source of B2M >

proposed the use of an irrmunoadsorbent column prepared with anti¬
serum to normal human serum and enriched with monospecific antiserum
to glycoproteins (11).

There would be very few antibodies to 32^ and

HLA antigens on the column since the concentration of these antigens is
quite low in normal sera,

so that the high amounts of &n\i and HLA

antigens in the urine of renal patients would pass right through
this column.

The other proteins also found in the urine of these

patients are proteins found normally in sera,

and so these would be

bound to the column.
A three step procedure using ultrafiltration,

gel filtration,

and isoelectric focusing (IEF) was also shown to be effective in
isolating human 32^ from urine (64).

A flat bed IEF method in poly¬

acrylamide gel showed high preparative capability.

This isolation

method utilized radioimmunoassay (RIA) to follow the yield of $2^
after each step.
32^

has also been isolated from guinea pig urine (16),

treatment of the animal with sodium chromate,
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following

an agent which leads to

renal tubular damage (5).

Two forms of

B2y were discovered.

They

were irnmmologically identical (shown by Ouchterlony lines of
identity),

but differed in amino acid composition (the minor form

had one fewer lysine residue) and isoelectric point.
cross-reacted with human and rabbit B2y *

Both forms

Siving lines of partial

identity in Ouchterlony immunodiffusion.

Variants of

^

Prove

to be particularly helpful in determining its biological activity and
evolutionary origin.

Guinea pig

volving ultrafiltraion,

was isolated by a procedure in¬

gel filtration with Sephadex G-100,

exchange chromatography using DEAE cellulose,
in borate buffer,

ion

zone electrophoresis

and a second gel filtration (16).

Total protein and

B2M activity were identified by absorbance at 280 nm and single radial
immunodiffusion,

respectively.

Purity of the isolated guinea pig

g2n was confirmed by several methods,
phoresis,

SDS - PAGE,

including agarose gel electro¬

amino acid analysis,

IEF,

and Ouchterlony

irnmunodif fusion.
Urine from rabbits poisoned with sodium chromate has been another
source from which B2u has been isolated (6,20,21).

The isolation pro¬

cedure was similar to that used for human and guinea pig 62^:
filtration,

gel chromatography,

cellulose chromatography.

zone electrophoresis,

and DEAE

The isolated rabbit $ \i shows a great

similarity with human B2u in molecular weight and size,
composition, presence of an intrachain disulfide loop,
phoretic mobility.

ultra¬

amino acid
and electro¬

Rabbit ($2^ has also shown homology with rabbit

IgG, particularly with the C^3 region (20).
sequences of £>2^ molecules from humans,

By examining amino acid

rabbits,

and dogs,

seen that B2U structure is highly conserved in evolution,

it can be
and that

B^and CU2 regions of immunoglobulins show more conservation of
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structure across species than the C^l and Cq3 regions (21)

.

The mouse homologue of human $2^ has been isolated (2,39,
53) and has been shown to form the snail subunit of H-2 antigens
coded for by K and D regions (serologically determined), just as
human B9y has been found to be a part of HLA antigens.

Its homology

to human 62M has been found to be a part of HLA antigens.
homology to human

Its

is demonstrated by its ability when on the

cell surface, to bind to anti-human 62^, which in the presence of
complement,

leads to lysis of the cell (53).

acid composition similarity to human $2^,

It also shows amino

including presence of an

intrachain disulfide bond, and antigenic similarity (39).

The

amino acid sequence shows much homology with human, dog, and rabbit
62^ as well as with mouse IgG,

particularly the C^3 region (2).

isolation procedure used for mouse BgtJ involved gel filtration,

The
ion

exchange chromatography, and column electrophoresis (39).
$2^ has been isolated from the urine of dogs with kidney

damage induced by surgery and X-rays (52,57).

A typical procedure

of ultrafiltration, gel filtration, starch gel electrophoresis, and
DEAE cellulose chromatography was used.

The amino acid sequence of

the dog homologue is similar to that of human B2I-1, but antisera to
the human B a will not precipitate dog B0p.

2

z

Lactollin is a molecule that had been previously isolated
and characterized, but was recognized only recently to be the cow
hcmologue of human B0m (31).

Its amino acid sequence is similar
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to that of the
species, however,

niolecules of other species.

Unlike other

it is not found in a monomeric form, but is

made up of four noncovalently linked subunits, each of about
12,000 MW.
Thus,

in all the different species, the general isolation

procedure for 62^ involved a combination of ultrafiltration, gel
filtration,

ion exchange chromatography, and zone electrophoresis.

The purity of the isolated $2^ 'ms confirmed by Ouchterlony immuno¬
diffusion, starch gel electrophoresis, or amino acid analysis.
Based on this information, a procedure for the isolation of
miniature swine 62^1 from serum was devised.
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Isolation of 3from miniature swine serum.
—-zr———'

MATERIALS AND METHODS
Animals„

A miniature swine from the inbred herd maintained

at the National Institutes of Health Animal Center, Poolesville,
Maryland, was poisoned with 20 mg/kg sodium chromate injected sub¬
cutaneously, as previously described (5).

In rabbits, the maximum

induced proteinuria occurs three to five days post-injection (20), so
urine (via a catheter) and a large sample of blood were collected from
the pig daily, from day three until day seven, when the pig was exsanguinated.
Sodium azide was added to the urine samples which were then kept frozen
at -20°C.

The blood samples were centrifuged and the sera were also

stored at -20°C.
Radioinminoassay (RIA).

In order to isolate miniature swine 62^

it was necessary to have an assay capable of detecting 32V1 activity in
column fractions from each step of the isolation procedure.

It had

been shown that a heterologous radioimmunoassay can be used to detect
homologues of ^ in sera from various vertebrate species (28).

There

is sufficient homology among the (3 2 a molecules of different species
for the B2a of one species to bind to the antisera against the
another species.

In the system described (28), significant binding

(about 60%) occurred between
(GAR) B2y

•

of

125

I-human f^a an<^ goat-anti-rabbit

This binding could be inhibited by unlabelled B2y

molecules from many species,

including the pig, which showed 81%

inhibition (28).

A homologous system using binding between

labelled BQy and antisera to 32y from the same species, was not
inhibited by B2y from another species,

so this could not be used.

The heterologous radioimmunoassay using inhibition of binding
between 125I-human 32y and GAR 32y was used in this isolation pro¬
cedure.

The GAR

B2y was obtained from Doctor Thomas Kindt

(National Institute of Allergy and Infectious Disease,
Institutes of Health),

National

and the IgG fraction of it was coupled to

Sepharose for use in the assay by Doctor Stuart Rudikoff (Laboratory
of Cell Biology,
Health).

National Cancer Institute,

National Institutes of

Purified human 32u was kindly provided by Doctor Howard

Grey (National Jewish Hospital Research Center, Denver,
It was labelled with

125

Colorado).

I by the lactoperoxidase-Sepharose gel

iodination method as previously described (24).
An RlA binding assay was set up in duplicate using a constant
amount of 125I-human B2y and several different quantities of Sepharose-bound GAR 32y.

Before use,

the

125

I-human B2u was diluted so

that each 100 yl contained about 20 ng of protein (as estimated by
125
absorbance at 280 nm) and 50,000 counts of
of this solution were:

1) emulphogene,

The

other components

an emulsifier added in a ratio

of about 25 to 30 yl per ml of solution;
(PBS),

I.

2)phosphate-buffered saline

pH 7, with 0.01% NaN^ and 1% bovine serum albumin (BSA);

57Cobalt,

about 500,000 counts per ml of solution.

3)

This was added as
125

a volume control to allow calculation of the bound

I-human 3

2^

125
without having to wash all the free
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I-human 32y from the precipitate (29).

Binding and inhibition assays were both set up in Brinkmann
microfuge tubes,

each brought to a final volume of 300 ul.

In

both of these assays a background tube containing only the PBS-BSA
125
buffer and an antigen control tube containing only
and the buffer were set up.
binding was also made,
bound antibody.

I-human B2y

A control for nonspecific antibody

using 125I-human f^y and another Sepharose-

All tubes were mixed continuously overnight at

4°C to optimize binding.

Then after centrifuging for one minute

in a Brinkmann microfuge,

about fifty percent of the supernatent

of each tube except the antigen control was removed.

The antigen
125

control tube was counted in its entirety,
counts possible.

to give the maximum

Samples were counted in a gamma counter capable

of counting two channels,

^^i and ^Co,

For the inhibition RIA assay,

an amount of GAR 32y was chosen

that resulted in fifty percent binding.
used for the binding assay,

for each tube.

In addition to the controls

a zero-inhibition or 100% binding control
125

was set up,
GAR B2y.

containing only the

I-human B2y and Sepharose-bound

A11 experimental samples contained these same quantities

of 125I-human 32u and GAR 32y plus an inhibitor which could be
serum,

urine,

eluate from a column,

or anything containing B2u.

Un¬

labelled human B2y was used as a standard inhibitor in several
different dilutions each time the assay was run.

Samples with a

high percent inhibition were diluted in the PBS-BSA buffer and
titered to find the maximum dilution that would still show inhibition.
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The percent binding was calculated by the formula:
Ea

<?£

=

100

-eA

XTa - e)

where E = 125I channel of the experimental
125

tube,

e = 57Co channel of the experimental tube,

of the antigen control,

A =

I channel

and a = 57Co channel of antigen control (29).

Additional corrections were made for background counts.

The percent

inhibition was calculated by the formula.
of zero inhibition control - 7cB of sample inhibitor

----TriT^
°1<E>

--

%I =
where

of zero inhibition 7»rvrvl‘T%nl
control"

is percent binding calculated as above (32).
Gel Chromatography.

100 ml aliquots of serum from the

poisoned pig were centrifuged at 15,000 rpm for 15 minutes to remove
any clumps and then chromatographed on a Sephadex G-75 column
(200 x 5 cm)

in borate buffer (0.2 M boric acid,

At a flow rate of 25 ml per hour,

About 270 18 ml

Absorbance at 280 nm ms used as an

indication of total protein.

Fractions showing B2w activity as

assayed by their ability to inhibit l2°I-human
in the RIA, were pooled.

a molecular weight greater than 2000 Daltons.

through the filter.

-GAR

binding

Pools were concentrated by ultraflltration

in an Amicon concentrator with a UM-2 filter,

assayed for B2u activity,

pH 8.0).

each 100 ml sample took about six

to seven days to be eluted from the column.
fractions were collected.

0.16 M NaCl,

retaining proteins with
The pass-through was

to be sure that 62a was not being lost

Initially a UM-10 filter had been used,

was too great a loss of B2u activity with this pore size.

-20-
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Isoelectric focusing (IEF).

1.0 ml of the UM-2 concentrate

was dialyzed overnight into glycine-HCl buffer to decrease the salt
concentration, using Spectropor 3 tubing, which retains molecules
greater than 3500 MW.

This sample was then loaded on a 110 ml

preparative IEF column run at 4°C for 24 hours.
solutions of pH range from 3 to 10 were used.

Carrier ampholyte
A solution of 50%

sucrose was used to form a density gradient to stabilize the protein
zones.

45 fractions of two mis each were analyzed for pH, for total

protein by absorbance at 280 nm, and forSgy activity by RIA.
Ion Exchange Chromatography.

Another aliquot of the UM-2

concentrate of serum $2^ was dialyzed overnight into 0.01 M Tris,
pH 8.6, and chromatographed on a 9 ml DEAE column equilibrated in
the same buffer.

A gradient elution device was connected to the

column, with a 60 ml mixing chamber containing the equilibration
buffer, and a 60 ml reservoir of equilibration buffer containing
0.2 M NaCl.

After the first 10 tubes of about 2 ml each were

collected, elution with the linear salt gradient was started.
50 more tubes were collected and all were assayed for
RIA.

Those with

About

activity by

activity were pooled and then concentrated by

ultrafiltration using the Amicon with a UM-2 filter.

This concentrate

was then equilibrated with sodium acetate 0.01 M, pH 5.6, by dialysis
overnight using Spectropor 3 (3500) tubing, and was placed on a CM
cellulose column equilibrated in the same buffer.

It was eluted with

a linear salt gradient made by mixing the 0.01M sodium acetate buffer
with equilibration buffer containing 0.2M NaCl.
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RESULTS

Radioinmunoassay.

I-labelling of the human B2P to be us©d

in the RIA resulted in a specific activity of 3010 cpm/ng.
binding assay using the

125
~ I-human B2P and GAR B2P antiserum showed

binding that plateaued at about 80 percent (Figure 1).
binding curve,
GAR $2^ to

I-human B2P that gave 50 percent binding,

from the binding curve.

shows the inhibition curve obtained.
occurred at about 65 percent.
in sera and urines,

as determined

Different concentrations of unlabelled

human Bp were used as standard inhibitors of binding,

and Figure 2

A plateau of inhibition

Fran the percent inhibition observed

an estimate of their B2P concentration could be

made using this standard curve.

past (28),

Based on this

the RIA inhibition assay was set up using the ratio of

125

B2P and pig

The RIA

^ bind to

125

62

This assumes that unlabelled human

I-human B2P to the same degree.

In the

human and pig sera have both shown about 80 percent

inhibition of the GAR B2P -

125
I-human

this assumption is probably valid.
tion of B2P

heterologous system,

so

By this estimation the concentra¬

in normal pig serum was 1.46 ug/ml.

The serum from a

pig poisoned with sodium chromate contained about 14.64 ug/ml,

about

a tenfold increase over the normal pig serum.
With this RIA inhibition assay established as a reliable method
of detecting and estimating the quantity of B2P activity,

it was then

used to determine fractions with B2^ activity in each step of the
isolation procedure.

The isolation described here was only done with the

serum from the poisoned pig,

but the urine will be dealt with in the

same manner.
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Gel Chromatography on Sephadex G-75.

Serum from the pig

poisoned with sodium chromate was chromatographed to separate out
small molecular weight molecules like B2y
the larger serum proteins.
major peak in OD280,

(a1:)OUl: 12,000 Daltons)

Figure 3 shows this separation, with the

presumably the major serum proteins,

from the column first,

from

eluted

followed by and not overlapping with the peak

having the greatest B2I-1 activity.

The first peak of 32u activity

may represent a snail amount of 32y that is still bound to histo¬
compatibility antigens,
proteins.

thus eluted with the higher molecular weight

The fractions after the major B2y peak that show B2y

activity may contain smaller molecular weight breakdown products of
B2y with less RIA inhibitory activity.

Two subsequent serum separa¬

tions on this Sephadex G-75 column showed that absorbance at 280 nm
and 32y activity occurred in approximately the same fractions as in
the first separation.
Isoelectric Focusing.
greatest B21J activity,

After pooling the fractions with the

as shown in Figure 3,

a portion of the con¬

centrated pool was analyzed by isoelectric focusing in an attempt
to separate B2y from molecules of the same size but of a different
charge or isoelectric point.

Although the pH gradient was good,

the

B2y activity did not focus in one fraction, but was scattered over
a wide pH range (Figure 4).

To determine whether the RIA might be

showing nonspecific inhibition by sucrose or by sane other molecule
used in the procedure,

the fractions were dialyzed.

in B2y activity that was somewhat more focused,
diffuse.

but still quite

Therefore this IEF procedure was abandoned,

using up more sample to repeat it.
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This resulted

rather than

Ion Exchange Chromatography.

It was decided instead to

separate the Sephadex G-75 concentrated pool by charge with a DEAEcellulose column.

The majority of the

did not pass straight

through the positively charged DEAE column (pH 8.6) but rather,
binding to the column,
this pH.

indicating the negative charge of pig B2u at

It was eluted only after the salt gradient was started

through the column,
peak,

tost of the B2u activity appeared in one distinct

pooled as shown in Figure 5.

This pool was then concentrated

and applied to a CM cellulose column (pH 5.6).
successful.
activity,

showed

This step was not

Fractions eluted from the column showed little

probably due to aggregation and failure to be eluted at the

acid pH.
A sumnary of results from the successful isolation steps was
conpiled in Table I.

The total amount of B2p resulting from each

purification step (as determined by RIA inhibition) was compared to
the total amount of B2p

in the original serum sample to obtain a

percent yield for each step.

Also the ratio of total 32p to total

protein as calculated by absorbance at 280 nm,

in the original

serum was compared to this ratio in each subsequent purification step,
to determine how manyfold a purification was achieved.

The net

result of the isolation procedure up to and including the DEAEcellulose ion exchange step was a 52.2% yield of 32p with respect
to the amount of B2p activity in the original serum,
than 1500-fold purification.
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and a greater

Te-rcent

BincU ng

Volume
Figure

.

GAR *

of

Radioimmunoassay binding curve.

(fiL.)
Concentration of GAR

32^ giving 50 percent binding is shown.
human

(20 ng.

were used in each microfuge tube).
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of

125

I-

Percent
Inhibit ion

Amount of human

Figure 2.

Radioimmunoassay inhibition curve.

P2P

(nff)

Standard unlabelled

human gg3 was used as inhibitor of a heterologous system
of 20 ng

125

I-human

^ and 75 yl goat anti-rabbit

62

$2^ per microfuge tube.

(GAR)

Percent

0^2/30

Elution

Figure 3.

tube

number

Sephadex G-75 gel filtration of pig serum.
column was run in 0.2n borate buffer,

A 200 x 5 cm

pH 8.0.

0DOgQ (---■»)

was used as a measure of total protein, and percent inhibition
1 nrz
of heterologous (I-human $2^ -GAR 32g) RIA binding (-)
was used as an index of 32^ activity.
greatest

Fractions with

62^ activity were pooled as indicated.
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,300t

.200-

od28 0
.100-

100

"

80-

Percent

fc0'

Inhibition
40-

20-

10

20

Elution
Figure 4.

Isoelectric focusing.

30

tube

40

number

The concentrated

peak from the

Sephadex G-75 column was applied to a 110 ml preparative IEF
column.

A gradient from pH3 to pHIO (••»■'*) was formed,

by a 50% sucrose gradient.

stabilized

The 0D2gQ(*-•) of the fractions is

shown on the upper part of the graph.

On the lower part,

the

$2^ activity (as determined by percent inhibition of a hetero¬
logous RIA inhibition systeri)
and the dialyzed (*.-a)
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is shown for the undialyzed (■—«)

fractions.

Pooled

Percent
Inhibition

t

Figure 5.

Piution

t-ube number

Ion exchange chromatography using DEAE cellulose.

Elution

diagram of the concentrated $ y peak (from the Sephadex G-75
column) applied to a DEAE cellulose column (0.01 M Tris,
pH 8.6).

Arrow marks the start of elution with 0.2 M NaCl.
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DISCUSSION
The isolation of miniature swine

was undertaken in order

to further investigate the structures of $2^ and the histocompati¬
bility antigens and their horology with the comparable molecules in
other species.

A remarkable retention of structural homology in the

32^ molecule has been shown in the many species studied thus far.

This

is reflected in iirmunologic cross-reactions that have been detected
between mouse and rabbit
assays (38),
(6).

and between mouse and human 62^ by RIA

and between rabbit and human $2^ by Ouchterlony analysis

This cross-reactivity was utilized in the present study, where

miniature swine B2M showed inhibition of a heterologous RIA system of
anc* human 62^-

goat-anti-human

This inhibition assay provided

a means of following the progress of the miniature swine B2U

isolation.

Whereas most other studies have used urine of poisoned animals
or of humans with kidney damage as a source of ^2^ >
done using serum of a poisoned pig,

32y activity.

which also showed high levels of

(The urine will be used in the same manner,

the maximal amount of

Isolation steps were basically

similar to those used in purification of human,

guinea pig,

Most of these used ultrafiltration,

and some form of ion

to get

available from each animal and provide more

B2y for chemical characterization).

and mouse 32y.

this study was

exchange chromatography.

rabbit,

gel chromatography,

Isoelectric focusing

had only been used in one of the human 32M isolation procedures (64),
but did not result in the same success in the present isolation schene
with the pig sera.

The failure of the B2U to focus may have been due

to nonspecific binding of B2P to proteins of different isoelectric points.
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Various attempts to further purify the pig 3oP by CM cellulose or gel
filtration at acidic pH have been unsuccessful,

possibly due to in¬

solubility of the pig 30y at this pH.

following the DEAE-

cellulose step,

Instead,

an additional gel chromatography step using Biogel-

P10 at a basic pH is currently being carried out.

Preliminary SDS gel

electrophoresis tests on the concentrated DEAE pool using a method
previously described (18,34) show a 11,500 MW peak free of most
contaminants.

This material is now being assayed for purity by amino

acid sequencing.

When sequenced,

it can be compared with the &2V

molecules of other species to determine the degree of homology.
Another use for the purified 32^
purified MSLA antigens,

is in reassociation studies with

to see if full alloantigenic activity can be

recovered.
Studies are being carried out now using the miniature swine $2^
isolated as described above to make an antiserum to swine $2^•

A

goat was injected intramuscularly at four sites with a total dose of
100-200 ug of purified swine 32t

(from the concentrated DEAE pool)

in

complete Freund's adjuvant and was boosted in the same manner at three
weeks.

Sera from weekly bleeds of the goat show precipitin bands with

the purified swine
to pig lymphocytes.

i-n Ouchterlony irrmunodiffusion and were cytotoxic
Preliminary SDS polyacrylamide gels with radio-

labelled miniature swine lymphocyte antigens indicate that the goatanti-swine 32^ antisera appears to precipitate histocompatibility
antigens.
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Further experiments will attempt to use the antiserum to swine
e2u to make an anti-32y inmunoadsorbent column for use m the isolation
of MSLA antigens.

There have been problems in the past with the use

of anti-BQy inmunoadsorbent columns as a means of isolating HLA
antigens, based on difficulty in elution of the antigens from the

anti-32^•

The noncovalent binding between B2y and the histocompati¬

bility antigens was readily disrupted in solution, but more stringent
conditions were required to elute the antigen from the anti-32y column.
This may have been due to aggregation of HLA molecules, forming a
network on the column which was difficult to elute.

With 0.1% SDS at

pH 7, however, 40-50% of the HLA antigenic activity put on the column
was able to be eluted (25).

Others have shown effective elution of

HLA antigen from an anti-B2y inmunoadsorbent column with excess B2y
or with 0.05 M glycine/HCl buffer (pH 2.4).

These methods gave 60 to

90 percent recovery of alloantigenic activity (54).

Anti-32y

inmuno¬

adsorbent columns may avoid the need for a whole series of fractionations
and may yield a product of higher purity than rnultistep procedures,
based on the specific binding of the 32y moiety of the MSLA antigens
to the anti-62y on the column.
precipitation

Anti-B2y can also be used in inrnuno-

gels, to attempt to precipitate out B2y 3-nd MSLA antigens

and any other cell surface molecules with which B2y may be associated.
When isolation and purification of the MSLA antigens is achieved,
these antigens can be sequenced and compared with irnrunoglobulin
structures and with H-2 and HLA antigens to establish homology.

Further

studies will look at homology within the three different homozygous
MHC types, AA, CC, and DD, that have been established in miniature
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swine (55).

Then the homology of AA,

histocompatibility antigens of the A,
investigated.

(X,
B,

and DD antigens with
and C

HLA regions can be

In the sequencing of MSLA antigens,

peptides are

formed and can be studied to see if they retain the alloantigenic
activity of the intact antigen.

Another use for purified MSLA

antigens is to insert than in liposomes or phospholipid model
membrane systems,

to see if they maintain their activity and are

able to stimulate mixed lymphocyte culture (MLC)

and cell-mediated

lympholysis (CML) reactions.
Therefore,

the isolation of miniature swine B2y not only

provides a purified 32y molecule for study and comparison with other
species,

but also facilitates the purification of MSLA antigens.

There are multiple uses for these purified MSLA antigens,

all leading

to a better understanding of the MHC and its role in transplantation
and various inmunological functions.
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